Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related deaths worldwide. Despite new technologies in diagnosis and treatment, the incidence and mortality of HCC continue rising. And its pathogenesis is still unclear. As a highly cons...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Cancer
Huvudupphovsmän: Liu, Hongying, Wang, Xieqi, Feng, Bing, Tang, Lipeng, Li, Weiping, Zheng, Xirun, Liu, Ying, Peng, Yan, Zheng, Guangjuan, He, Qinglian
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006993/
https://ncbi.nlm.nih.gov/pubmed/29914442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4458-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk